CTNNB1 and neoplasm: Elevating Ctnnb1 in high-miR-17-92 cells does not raise β-catenin protein levels, suggesting that other factors regulated by miR-17-92 contribute to tumor inhibition, potentially negatively affecting β-catenin production.